Role of diabetes in the development of acute respiratory distress syndrome*

Shun Yu, David C. Christiani, B. Taylor Thompson, Ednan K. Bajwa, Michelle Ng Gong

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

OBJECTIVES:: Diabetes has been associated with decreased development of acute respiratory distress syndrome in some, but not all, previous studies. Therefore, we examined the relationship between diabetes and development of acute respiratory distress syndrome and whether this association was modified by type of diabetes, etiology of acute respiratory distress syndrome, diabetes medications, or other potential confounders. DESIGN:: Observational prospective multicenter study. SETTING:: Four adult ICUs at two tertiary academic medical centers. PATIENTS:: Three thousand eight hundred sixty critically ill patients at risk for acute respiratory distress syndrome from sepsis, pneumonia, trauma, aspiration, or massive transfusion. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Diabetes history was present in 25.8% of patients. Diabetes was associated with lower rates of developing acute respiratory distress syndrome on univariate (odds ratio, 0.79; 95% CI, 0.66-0.94) and multivariate analysis (adjusted odds ratio, 0.76; 95% CI, 0.61-0.95). After including diabetes medications into the model, diabetes remained protective (adjusted odds ratio, 0.75; 95% CI, 0.59-0.94). Diabetes was associated with decreased development of acute respiratory distress syndrome both in the subgroup of patients with sepsis (adjusted odds ratio, 0.77; 95% CI, 0.61-0.97) and patients with noninfectious etiologies (adjusted odds ratio, 0.30; 95% CI, 0.10-0.90). The protective effect of diabetes on acute respiratory distress syndrome development is not clearly restricted to either type 1 (adjusted odds ratio, 0.50; 95% CI, 0.26-0.99; p = 0.046) or type 2 (adjusted odds ratio, 0.77; 95% CI, 0.60-1.00; p = 0.050) diabetes. Among patients in whom acute respiratory distress syndrome developed, diabetes was not associated with 60-day mortality on univariate (odds ratio, 1.11; 95% CI, 0.80-1.52) or multivariate analysis (adjusted odds ratio, 0.81; 95% CI, 0.56-1.18). CONCLUSIONS:: Diabetes is associated with a lower rate of acute respiratory distress syndrome development, and this relationship remained after adjusting for clinical differences between diabetics and nondiabetics, such as obesity, acute hyperglycemia, and diabetes-associated medications. In addition, this association was present for type 1 and 2 diabetics and in all subgroups of at-risk patients.

Original languageEnglish (US)
Pages (from-to)2720-2732
Number of pages13
JournalCritical Care Medicine
Volume41
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Adult Respiratory Distress Syndrome
Odds Ratio
Sepsis
Multivariate Analysis
Aspiration Pneumonia
Critical Illness
Hyperglycemia
Multicenter Studies
Obesity
History
Prospective Studies
Mortality
Wounds and Injuries

Keywords

  • Acute lung injury
  • Acute respiratory distress syndrome
  • Diabetes mellitus
  • Hyperglycemia
  • Risk factors

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Role of diabetes in the development of acute respiratory distress syndrome*. / Yu, Shun; Christiani, David C.; Thompson, B. Taylor; Bajwa, Ednan K.; Gong, Michelle Ng.

In: Critical Care Medicine, Vol. 41, No. 12, 12.2013, p. 2720-2732.

Research output: Contribution to journalArticle

Yu, Shun ; Christiani, David C. ; Thompson, B. Taylor ; Bajwa, Ednan K. ; Gong, Michelle Ng. / Role of diabetes in the development of acute respiratory distress syndrome*. In: Critical Care Medicine. 2013 ; Vol. 41, No. 12. pp. 2720-2732.
@article{159c1cabf1734c30a3c8f8aa473cabed,
title = "Role of diabetes in the development of acute respiratory distress syndrome*",
abstract = "OBJECTIVES:: Diabetes has been associated with decreased development of acute respiratory distress syndrome in some, but not all, previous studies. Therefore, we examined the relationship between diabetes and development of acute respiratory distress syndrome and whether this association was modified by type of diabetes, etiology of acute respiratory distress syndrome, diabetes medications, or other potential confounders. DESIGN:: Observational prospective multicenter study. SETTING:: Four adult ICUs at two tertiary academic medical centers. PATIENTS:: Three thousand eight hundred sixty critically ill patients at risk for acute respiratory distress syndrome from sepsis, pneumonia, trauma, aspiration, or massive transfusion. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Diabetes history was present in 25.8{\%} of patients. Diabetes was associated with lower rates of developing acute respiratory distress syndrome on univariate (odds ratio, 0.79; 95{\%} CI, 0.66-0.94) and multivariate analysis (adjusted odds ratio, 0.76; 95{\%} CI, 0.61-0.95). After including diabetes medications into the model, diabetes remained protective (adjusted odds ratio, 0.75; 95{\%} CI, 0.59-0.94). Diabetes was associated with decreased development of acute respiratory distress syndrome both in the subgroup of patients with sepsis (adjusted odds ratio, 0.77; 95{\%} CI, 0.61-0.97) and patients with noninfectious etiologies (adjusted odds ratio, 0.30; 95{\%} CI, 0.10-0.90). The protective effect of diabetes on acute respiratory distress syndrome development is not clearly restricted to either type 1 (adjusted odds ratio, 0.50; 95{\%} CI, 0.26-0.99; p = 0.046) or type 2 (adjusted odds ratio, 0.77; 95{\%} CI, 0.60-1.00; p = 0.050) diabetes. Among patients in whom acute respiratory distress syndrome developed, diabetes was not associated with 60-day mortality on univariate (odds ratio, 1.11; 95{\%} CI, 0.80-1.52) or multivariate analysis (adjusted odds ratio, 0.81; 95{\%} CI, 0.56-1.18). CONCLUSIONS:: Diabetes is associated with a lower rate of acute respiratory distress syndrome development, and this relationship remained after adjusting for clinical differences between diabetics and nondiabetics, such as obesity, acute hyperglycemia, and diabetes-associated medications. In addition, this association was present for type 1 and 2 diabetics and in all subgroups of at-risk patients.",
keywords = "Acute lung injury, Acute respiratory distress syndrome, Diabetes mellitus, Hyperglycemia, Risk factors",
author = "Shun Yu and Christiani, {David C.} and Thompson, {B. Taylor} and Bajwa, {Ednan K.} and Gong, {Michelle Ng}",
year = "2013",
month = "12",
doi = "10.1097/CCM.0b013e318298a2eb",
language = "English (US)",
volume = "41",
pages = "2720--2732",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Role of diabetes in the development of acute respiratory distress syndrome*

AU - Yu, Shun

AU - Christiani, David C.

AU - Thompson, B. Taylor

AU - Bajwa, Ednan K.

AU - Gong, Michelle Ng

PY - 2013/12

Y1 - 2013/12

N2 - OBJECTIVES:: Diabetes has been associated with decreased development of acute respiratory distress syndrome in some, but not all, previous studies. Therefore, we examined the relationship between diabetes and development of acute respiratory distress syndrome and whether this association was modified by type of diabetes, etiology of acute respiratory distress syndrome, diabetes medications, or other potential confounders. DESIGN:: Observational prospective multicenter study. SETTING:: Four adult ICUs at two tertiary academic medical centers. PATIENTS:: Three thousand eight hundred sixty critically ill patients at risk for acute respiratory distress syndrome from sepsis, pneumonia, trauma, aspiration, or massive transfusion. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Diabetes history was present in 25.8% of patients. Diabetes was associated with lower rates of developing acute respiratory distress syndrome on univariate (odds ratio, 0.79; 95% CI, 0.66-0.94) and multivariate analysis (adjusted odds ratio, 0.76; 95% CI, 0.61-0.95). After including diabetes medications into the model, diabetes remained protective (adjusted odds ratio, 0.75; 95% CI, 0.59-0.94). Diabetes was associated with decreased development of acute respiratory distress syndrome both in the subgroup of patients with sepsis (adjusted odds ratio, 0.77; 95% CI, 0.61-0.97) and patients with noninfectious etiologies (adjusted odds ratio, 0.30; 95% CI, 0.10-0.90). The protective effect of diabetes on acute respiratory distress syndrome development is not clearly restricted to either type 1 (adjusted odds ratio, 0.50; 95% CI, 0.26-0.99; p = 0.046) or type 2 (adjusted odds ratio, 0.77; 95% CI, 0.60-1.00; p = 0.050) diabetes. Among patients in whom acute respiratory distress syndrome developed, diabetes was not associated with 60-day mortality on univariate (odds ratio, 1.11; 95% CI, 0.80-1.52) or multivariate analysis (adjusted odds ratio, 0.81; 95% CI, 0.56-1.18). CONCLUSIONS:: Diabetes is associated with a lower rate of acute respiratory distress syndrome development, and this relationship remained after adjusting for clinical differences between diabetics and nondiabetics, such as obesity, acute hyperglycemia, and diabetes-associated medications. In addition, this association was present for type 1 and 2 diabetics and in all subgroups of at-risk patients.

AB - OBJECTIVES:: Diabetes has been associated with decreased development of acute respiratory distress syndrome in some, but not all, previous studies. Therefore, we examined the relationship between diabetes and development of acute respiratory distress syndrome and whether this association was modified by type of diabetes, etiology of acute respiratory distress syndrome, diabetes medications, or other potential confounders. DESIGN:: Observational prospective multicenter study. SETTING:: Four adult ICUs at two tertiary academic medical centers. PATIENTS:: Three thousand eight hundred sixty critically ill patients at risk for acute respiratory distress syndrome from sepsis, pneumonia, trauma, aspiration, or massive transfusion. INTERVENTIONS:: None. MEASUREMENTS AND MAIN RESULTS:: Diabetes history was present in 25.8% of patients. Diabetes was associated with lower rates of developing acute respiratory distress syndrome on univariate (odds ratio, 0.79; 95% CI, 0.66-0.94) and multivariate analysis (adjusted odds ratio, 0.76; 95% CI, 0.61-0.95). After including diabetes medications into the model, diabetes remained protective (adjusted odds ratio, 0.75; 95% CI, 0.59-0.94). Diabetes was associated with decreased development of acute respiratory distress syndrome both in the subgroup of patients with sepsis (adjusted odds ratio, 0.77; 95% CI, 0.61-0.97) and patients with noninfectious etiologies (adjusted odds ratio, 0.30; 95% CI, 0.10-0.90). The protective effect of diabetes on acute respiratory distress syndrome development is not clearly restricted to either type 1 (adjusted odds ratio, 0.50; 95% CI, 0.26-0.99; p = 0.046) or type 2 (adjusted odds ratio, 0.77; 95% CI, 0.60-1.00; p = 0.050) diabetes. Among patients in whom acute respiratory distress syndrome developed, diabetes was not associated with 60-day mortality on univariate (odds ratio, 1.11; 95% CI, 0.80-1.52) or multivariate analysis (adjusted odds ratio, 0.81; 95% CI, 0.56-1.18). CONCLUSIONS:: Diabetes is associated with a lower rate of acute respiratory distress syndrome development, and this relationship remained after adjusting for clinical differences between diabetics and nondiabetics, such as obesity, acute hyperglycemia, and diabetes-associated medications. In addition, this association was present for type 1 and 2 diabetics and in all subgroups of at-risk patients.

KW - Acute lung injury

KW - Acute respiratory distress syndrome

KW - Diabetes mellitus

KW - Hyperglycemia

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84889250514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889250514&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e318298a2eb

DO - 10.1097/CCM.0b013e318298a2eb

M3 - Article

AN - SCOPUS:84889250514

VL - 41

SP - 2720

EP - 2732

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 12

ER -